Isu Abxis, Foreign Investors Net Buy 52,169 Shares... Stock Price Up 0.55%
Isu Abxis ranked among the top searched stocks for 10 days in the past month.
As of 11:30 AM on the 4th, Isu Abxis is trading at 9,120 KRW, up 0.55% from the previous day. This is a 35.77% decrease compared to February 16. Isu Abxis, an affiliate of the Isu Group, is known as a company that develops antibiotic treatments and provides medical services.
Today, foreigners have tentatively net purchased 52,169 shares. Over the past five days, individual investors have net purchased 89,881 shares, while foreigners and institutions have net sold 64,837 shares and 9,993 shares, respectively.
On February 23, Isu Abxis was a market topic with the headline "Rising on agreement to produce Russian COVID-19 vaccine."
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- Experts Shocked by Record Numbers: "Just the Tip of the Iceberg" — The Identity Behind the 90% Dominating Teens [Chuiyakgukga]⑨
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.